QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Releases Second-Quarter 2021 Financial Numbers
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing compounds with known activity and safety profiles for the treatment of rare and other diseases with unmet medical needs, has reported its interim financial results and business highlights for the three- and six-month periods ended Feb. 28, 2021. Highlights of the report include the closing of the company’s initial public offering, as well as additions to both the Tryp executive team and board of directors. The report also noted progress with the company’s manufacturing program for synthetic psilocybin as well as a collaboration with Jennifer Miller MD as…